Process validation ensures manufacturing consistency, reduces deviations, prevents rework, improves resource utilization, and facilitates production scale-up. As a direct result, it accelerates time t...
Read moreOn Tuesday, November 18, the consortium of the European project MILenARI (Mediterranean International Lentivirus ARI) held its inaugural meeting online, with the participation of all partners and repr...
Read moreReaching the point where GMP manufacturing becomes a real requirement is a defining milestone for any biologics program. At this stage, development decisions are no longer theoretical. They directly a...
Read moreMonQAI is a digitalform payment aimed at hospitals, ethics and drug research committees and clinical trial promoters that use generative artificial intelligence (AI) to streamline and optimize the cli...
Read moreLa sexta edición del encuentro, organizado por AseBio y el Ayuntamiento, reunirá el 21 de abril en el Palacio de Congresos a empresas e instituciones punteras para impulsar soluciones sostenibles al...
Read moreCRB Bio II, a life sciences–focused fund managed by CRB Health Tech (formerly CRB Inverbio), has completed its divestment from Health in Code (HiC), closing a full value creation cycle that began wi...
Read moreGMP manufacturing pitfalls that delay biologics production can increase costs, disrupt clinical timelines, and compromise regulatory readiness if not addressed early.
Read moreEn el marco de la BCN Health Innovation Week de Biocat, ambas instituciones han presentado el JointLAB IQS-SJD, una plataforma pionera para acelerar la transferencia tecnológica en salud materno-feta...
Read moreMonQAI is a digital platform aimed at hospitals, drug research ethics committees and clinical trial sponsors that uses generative artificial intelligence (AI) to streamline and optimize the clinical s...
Read moreThe conference was organised by the UAI (Innovation Support Unit) of the IiSGM (Gregorio Marañón Health Research Institute) and was sponsored by GENESIS Biomed, HOFFMANN EITLE, DINAMIZA Health Resea...
Read more3PBIOVIAN and the Colombia INC has signed a contract to carry out the development of a biosimilar monoclonal antibody (mAb) for an oncology indication, marking the first biosimilar mAb to be developed...
Read more3PBIOVIAN provides end-to-end CDMO services for animal health, supporting the development and GMP manufacturing of veterinary vaccines and biologics. With proven expertise in recombinant proteins, vir...
Read more